Beyond the typical immune effector cell-associated neurotoxicity syndrome: Characterizing non-immune effector cell-associated neurotoxicity syndrome neurological complications in chimeric antigen receptor T-cell therapy—A retrospective analysis

Dr. Jasmin Jo interviews Dr. Haroon Ahmad and Dr. Lily Pham on their recent manuscript, titled "Beyond the typical immune effector cell-associated neurotoxicity syndrome: Characterizing non-immune effector cell-associated neurotoxicity syndrome neurological complications in chimeric antigen receptor T-cell therapy—A retrospective analysis Podcast Host and Interviewee:  Host: DR. Jasmin Jo Interviewee: Haroon Ahmad and Lily Pham   Podcast Description: "

Dr. Daniel Zamler interviews Dr. Amy Heimberger on the current limitations to myeloid therapy- specific discussions include combination therapies, plasticity of myeloid cells, translation, patient stratification and outlook. Podcast Host and Interviewee:  Host: Dr. Daniel Zamler Interviewee: Dr. Amy Heimberger

Dr. Evan Noch interviews Dr. Nathan Dalton on his journey founding the charity Baking for Brain Cancer to support brain tumor research in Australia.

Dr. Daniel Zamler interviews Dr. Sriram Venneti on recent advances in Ependymoma research. Topics include subtyping, targeted therapies, and what is currently needed in the field. Podcast Host and Interviewee:  Host: Dr. Daniel Zamler Interviewee: Dr. Sriram Venneti

What if a tumor's hidden dependence on Ras could become its biggest vulnerability? In this episode, Dr. Stephanie Grace Spurgeon and Dr. Cynthia Hawkins explain how their team engineered a targeted biologic to shut down Ras signaling in diffuse midline glioma—and what their preclinical findings reveal about reaching these aggressive tumors, including disease that spreads beyond the brainstem. Could this approach open a new path toward treatment? Listen to find out. Interviewer: Dr. Jiasen He Guests: Drs. Stefanie-Grace Sbergio, Cynthia Hawkins, Jiasen He 

Dr. Matthew Sun interviews Dr. Ramona-Alexandra Todea and Dr. Riccardo Ludovichetti at University hospital Zurich about their paper recently published in Neuro-oncology advances, titled "Prediction of treatment failure in patients with glioblastoma with perfusion MRI and molecular biomarkers" Podcast Host and Interviewee:  Host: Dr. Matthew Sun Interviewees: Dr. Ramona-Alexandra Todea and Dr. Riccardo Ludovichetti    

Live from EANO, Dr. Evan Noch interviews EANO President Dr.  Michael Platten and EANO President-Elect Dr. Roberta Rudà

Podcast Host and Interviewee: Host: Dr. Daniel Zamler Interviewee: Dr. Pedro Lowenstein   Podcast Description: Dr. Daniel Zamler interviews Dr. Pedro Lowenstein on how recruiting dendritic cells to the tumor microenvironment has a beneficial effect, as shown in their recent clinical trial. Oncostreams and the effect of tumor organization on pathogenesis are also discussed.

Jayden Ha interviews SaRena Eves, a certified medical dosimetrist. The episode focuses on dosimetry as a career, its education requirements, and day-to-day routine. Host: Jayden Interviewee: SaRena Eves  

Dr. Franziska Ippen interviews Drs. George Petrescu, Marjolein Geurta, and Tobias Weiss on updates and perspectives from EANO's Youngsters Committee Podcast Host and Interviewee:  Host: Franziska Ippen Interviewee: George Petrescu, Marjolein Geurts, Tobias Weiss